Answers are grounded in this paper and cite their sources.
A large microRNA cluster on chr19q13.42 is a transcriptional hallmark of type A and AB thymomas. Furthermore, this cluster activates the PI3K pathway, suggesting the possible exploration of PI3K inhibitors in patients with these subtypes of tumour. This work has led to the initiation of a phase II clinical trial of PI3K inhibition in relapsed or refractory thymomas (http://clinicaltrials.gov/ct2/show/NCT02220855).
No takes yet. Share an insight, caveat, or question.
Radovich et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: